Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Review of Persistent Post-COVID Syndrome (PPCS).
Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. Oronsky B, et al. Among authors: kesari s. Clin Rev Allergy Immunol. 2023 Feb;64(1):66-74. doi: 10.1007/s12016-021-08848-3. Epub 2021 Feb 20. Clin Rev Allergy Immunol. 2023. PMID: 33609255 Free PMC article. Review.
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials.
Oronsky B, Paulmurugan R, Foygel K, Scicinski J, Knox SJ, Peehl D, Zhao H, Ning S, Cabrales P, Summers TA Jr, Reid TR, Fitch WL, Kim MM, Trepel JB, Lee MJ, Kesari S, Abrouk ND, Day RM, Oronsky A, Ray CM, Carter CA. Oronsky B, et al. Among authors: kesari s. Expert Opin Investig Drugs. 2017 Jan;26(1):109-119. doi: 10.1080/13543784.2017.1268600. Expert Opin Investig Drugs. 2017. PMID: 27935336 Review.
COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making.
Larson C, Oronsky B, Goyal S, Ray C, Hedjran F, Hammond TC, Kesari S, Caroen S, Lybeck M, Dobalian VE, Oronsky A, Reid T. Larson C, et al. Among authors: kesari s. Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188412. doi: 10.1016/j.bbcan.2020.188412. Epub 2020 Aug 20. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32827582 Free PMC article. Review.
Mesenchymal stem cells in the treatment of severe COVID-19.
Kesari S, Kasper GC, Verkh L, Hammond TC, Matal ML, Hammerling JW, Tankovich N, Lim AP, Zhao KH, Juarez T, Redfern RE, Gill JM, Nomura N, Hiemer A, Heng A, Shoemaker J. Kesari S, et al. Transl Med Commun. 2021;6(1):16. doi: 10.1186/s41231-021-00095-0. Epub 2021 Aug 9. Transl Med Commun. 2021. PMID: 34395912 Free PMC article. No abstract available.
Correction to: Mesenchymal stem cells in the treatment of severe COVID-19.
Kesari S, Kasper GC, Verkh L, Hammond TC, Matal ML, Hammerling JW, Tankovich N, Lim AP, Zhao KH, Juarez T, Redfern RE, Gill JM, Nomura N, Hiemer A, Heng A, Shoemaker J. Kesari S, et al. Transl Med Commun. 2021;6(1):19. doi: 10.1186/s41231-021-00098-x. Epub 2021 Aug 23. Transl Med Commun. 2021. PMID: 34458585 Free PMC article.
BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors.
Kesari S, Bessudo A, Gastman BR, Conley AP, Villaflor VM, Nabell LM, Madere D, Chacon E, Spencer C, Li L, Larson C, Reid T, Caroen S, Oronsky B, Stirn M, Williams J, Barve MA. Kesari S, et al. Future Oncol. 2022 Sep;18(29):3245-3254. doi: 10.2217/fon-2022-0481. Epub 2022 Aug 11. Future Oncol. 2022. PMID: 35950603 Free article.
424 results